About
Claus Crone Fuglsang is Chief Scientific Officer of Novonesis, the biosolutions company formed from the combination of Novozymes and Chr. Hansen. He joined Novozymes in 1993 and has led R&D in both Denmark and the United States, with deep expertise in enzymes, microbes, and industrial biotechnology. Public sources portray him as a senior scientific and innovation leader rather than an investor or fund manager.
Areas of interest
industrial biotechnologyenzymesmicroorganismsprotein discoverybioprocessingmicrobiomeprobioticshuman healthfood technologyagriculturebioenergysustainabilitycircular economyAI-enabled R&D